Azitra is trading 5.5% down at $0.14, with no clear company-specific catalyst identified for August 12, 2026.

  • Its investor-relations page shows the latest release dated July 15, covering ATR-COSF cosmetic-program results.
  • The broader market is higher, so macro sentiment does not explain the decline.
  • The move appears speculative or liquidity-driven, but available coverage does not establish a definitive cause.